ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Mitsui and Company Ltd (PK)

Mitsui and Company Ltd (PK) (MITSY)

454.15
0.00
(0.00%)
Closed September 27 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
454.15
Bid
432.85
Ask
457.95
Volume
-
0.00 Day's Range 0.00
326.41 52 Week Range 550.00
Market Cap
Previous Close
454.15
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
12,765
Shares Outstanding
75,679,458
Dividend Yield
7.21%
PE Ratio
0.00
Earnings Per Share (EPS)
14.06k
Revenue
13.36T
Net Profit
1.06T

About Mitsui and Company Ltd (PK)

Mitsui & Co., Ltd. is engaged in the provision of services to facilitate trade and promote the development of commerce and industry around the world as an integrated trading company. Co.'s principal products include metal: iron ore, non-ferrous metals; machinery & information: machinery and the coor... Mitsui & Co., Ltd. is engaged in the provision of services to facilitate trade and promote the development of commerce and industry around the world as an integrated trading company. Co.'s principal products include metal: iron ore, non-ferrous metals; machinery & information: machinery and the coordination of plant and information industry related projects; chemical/energy: energy related resources, organic chemicals, non-organic chemicals, petrochemicals, and optical chemical products; and consumer products: foods, coffee, tea, fish, spice, and alcohols; industrial materials. Show more

Sector
Durable Goods-wholesale, Nec
Industry
Diversified Wholesale-durable
Headquarters
Chiyoda, Tokyo, Jpn
Founded
1985
Mitsui and Company Ltd (PK) is listed in the Durable Goods-wholesale sector of the OTCMarkets with ticker MITSY. The last closing price for Mitsui (PK) was $454.15. Over the last year, Mitsui (PK) shares have traded in a share price range of $ 326.41 to $ 550.00.

Mitsui (PK) currently has 75,679,458 shares outstanding. The market capitalization of Mitsui (PK) is $34.37 billion. Mitsui (PK) has a price to earnings ratio (PE ratio) of 0.00.

MITSY Latest News

Shell Acquires Full Working Interest in Gulf of Mexico Kaikias Field

By Ben Glickman Shell Offshore, a subsidiary of Shell, acquired the remaining 20% working interest in a Gulf-of-Mexico field it doesn't currently own. The oil-and-gas giant now has 100...

RWE, Mitsui, Osaka Gas Secure Japanese Offshore Wind-Farm Project

By Nina Kienle RWE said it has been selected together with Mitsui & Co. and Osaka Gas by the Japanese government to construct and operate a commercial-scale wind farm off the coast of two...

Galp Unveils EUR650 Million Investments in Biofuels, Hydrogen Facilities

By Mauro Orru Galp said Monday that some 650 million euros ($692 million) would be invested in two large-scale projects in Portugal to reduce the carbon footprint of the Sines refinery and its...

Japanese Trading Giant Mitsui Invests in U.S. Regenerative Farming Company -- OPIS

Mitsui & Co. has invested an undisclosed amount in U.S. regenerative agriculture company RRG Nature Based Solutions, the Japanese trading giant said Thursday. Through this investment, Mitsui...

Celanese, Mitsui Sign Food-Ingredients Joint-Venture Agreement

By Sabela Ojea Celanese and Mitsui & Co. said Thursday that they signed an agreement to launch a food-ingredients joint venture following a long-term strategic partnership. Chemical and...

Mitsui & Co. to Keep Pursuing Natural-Gas Project in Russia

By Chieko Tsuneoka TOKYO--The chief executive of Mitsui & Co., a Japanese trading company partly owned by Warren Buffett's Berkshire Hathaway, said Tuesday that his company would continue...

Berkshire Hathaway Raises Stakes in Five Japan Trading Houses, Nikkei Reports

Berkshire Hathaway Inc. increased its stakes in five major Japanese trading companies to 7.4% each, Japanese business daily Nikkei reported Tuesday, citing an interview with Chief Executive Warren...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
114.153.21590909091440455.42411.515007437.01093876DR
440.59.79088601475413.65455.42384.8112942409.6312005DR
12-19.76-4.16956806145473.91487.5335.7312765405.63934258DR
26-20.85-4.38947368421475550335.737288420.58767397DR
5275.27519.868030353378.875550326.414961411.96078556DR
156225.4898.6049766038228.675502004059330.65691171DR
260291.99180.062900839162.16550123.83446286.45503804DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
$ 0.02914
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0387
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.02914
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0387
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
SMMESmartMetric Inc (PK)
$ 0.00015
(0.00%)
5M
HCMCHealthier Choices Management Corporation (PK)
$ 0.0001
(0.00%)
3M
ACGBYAgricultural Bank of China (PK)
$ 13.08
(0.00%)
2M
CAOVYChina Overseas Land and Investment Ltd (PK)
$ 9.53
(0.00%)
1.56M
CICHFChina Construction Bank (PK)
$ 0.794425
(0.00%)
843.43k

Discussion

View Full Feed
Risk Risk 5 minutes ago
This is awesome. Thanks TJ. Need a lot of patience.
AFFU
nidan7500 nidan7500 5 minutes ago
georgejjiUS FDA approves Bristol Myers' schizophrenia drug

FDA approval for new type of schizophrenia treatment

ristol prices drug at $1,850 a month

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-dr
AVXL
RobotDroid RobotDroid 6 minutes ago
Another wrong opinion. Too funny how the cult looks at other companies data and thinks it applies to nwbo. It doesn't, no other compnay has the worst, inept mute mismanagement clown show in history.
NWBO
Risk Risk 6 minutes ago
TJ that’s better dream :)) OS dream big :))
AFFU
Wingsjr Wingsjr 7 minutes ago
Thx, brother. 👍
FNMA
Golden Cross Golden Cross 7 minutes ago
$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi
XXII
GetSeriousOK GetSeriousOK 8 minutes ago
Call her then.

And don't accept "we'll release a PR when it's appropriate" for an answer.

Personally, I wouldn't believe anything she told you over the phone, but that's just my experience with biotech CEO phone calls. Whatever she says, tell her "Put that in writing.
BIEL
Golden Cross Golden Cross 8 minutes ago
$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi
XXII
weedtrader420 weedtrader420 8 minutes ago
XRP✊😎 Lynyrd Skynyrd SIMPLE MAN $1 TARGET
XRPUSD
MFranny MFranny 8 minutes ago
That's where, at the very least, Steven Walker should have been present. But he wasn't...
SHMP
GetSeriousOK GetSeriousOK 9 minutes ago
Sorry, the patents expired due to non-payment of maintenance fees.

"Extended to 2029" refers to the Patent Term Restoration (PTR) extension. IF Whelan had paid the maintenance fees, the patents would be active until 2029. Without that extension they would have expired in 2023, twenty
BIEL
manibiotech manibiotech 9 minutes ago
In that case they will have to take personal responsibility and be held accountable . Current strategy transfers 100% of responsibility and blame on someone else . So what’s the incentive to change ?
NWBO
zj3001 zj3001 9 minutes ago
$RNAZ everyone so focused on a price per share, but no one ever talks about market cap. Imagine Transcode getting a $50-200m upfront payment to partner with Big Pharma. What do you think that makes the value of the company?

What if they get fda fast track approval?

It
RNAZ
Alexulf Alexulf 9 minutes ago
We continue the climb up!

Strong news do the trick :-)

https://aitx.ai/
AITX
MetaMonster MetaMonster 10 minutes ago
Ceo Mark White is in rehab for drug addiction
FOXO
FeMike FeMike 10 minutes ago
That's just a guess, and probably wrong.
You realize you are an absolute moron, right? 3 months ago after the ASM, when I said we hadn't gotten an RFI yet and were still in phase 1, you told me that was "100% not true". When i asked you to clarify, you said:
We are not in phase 1. Th
ASM
James56 James56 10 minutes ago
Soon.
MDCE
2020trader 2020trader 10 minutes ago
that would be a wasted call...lol
CLNV
1vman 1vman 10 minutes ago
*****Wowzah🟥🟥🟥🟥 Power2theGMEshorters/brilliant, interest has faded big time here

ENOUGH SAID
GME
arachnodude arachnodude 10 minutes ago
Consider demand influences the rate at which they produce, but the capacity reflects what the facility is capable of producing under optimal conditions, regardless of how much is currently being ordered or sold.
KBLB
kid70 kid70 11 minutes ago
Hopefully, we can beat yesterday volume. Lol
UBQU
Deano361 Deano361 11 minutes ago
Now from 100 to 500m?
FUNR